• Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
    • Examining Transportation
LogoWashington Examiner
LogoWashington Examiner
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
    • Examining Transportation
More
    Home Tags FDA

    Tag: FDA

    Mifepristone tablets sit on a table
    Crime

    Louisiana man charged with drugging 23-week pregnant woman with abortion pill

    Gabrielle M. Etzel -
    June 12, 2026 5:08 pm
    0
    Signage outside the US Food and Drug Administration headquarters in Silver Spring, Maryland, on April 28, 2026. (Valerie Plesch/Bloomberg via Getty Images
    Op-Eds

    Reform FDA advisory committees and put rare disease patients first

    Trica Flanagan -
    June 11, 2026 11:00 am
    0
    U.S. Attorney General Pam Bondi and U.S. Secretary of Health and Human Services Robert Kennedy Jr. look on while vape products are on display in the foreground during a press conference in Bensonville, Ill., Wednesday, Sept. 10, 2025, in Chicago. (AP Photo/Paul Beaty)
    Fairness and Justice

    Tobacco policy should reflect the world as it is

    Jeffrey A. Singer, Caleb O. Brown -
    June 11, 2026 6:00 am
    0
    Boxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on March 16, 2022. Louisiana Gov. Jeff Landry has signed a first-of-its-kind bill Friday, May 24, classifying two abortion-inducing drugs, mifepristone and misoprostol, as controlled and dangerous substances. (AP Photo/Allen G. Breed)
    Healthcare

    GOP attorneys general demand abortion pill water safety tests from EPA

    Gabrielle M. Etzel -
    June 10, 2026 11:46 am
    0
    The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. (AP Photo/David J. Phillip)
    Op-Eds

    Shut down the FDA’s failed GLP-1 green list

    Michael Burgess -
    June 10, 2026 6:00 am
    0
    Collage of pro-life activists, mifepristone packaging, and the FDA logo.
    Healthcare

    Pro-life activists skeptical of FDA abortion pill study

    Gabrielle M. Etzel -
    June 10, 2026 6:00 am
    0
    HHS Secretary Robert F. Kennedy Jr.
    Healthcare

    Food industry hopes transparency efforts will appease MAHA 

    Gabrielle M. Etzel -
    June 9, 2026 5:00 am
    0
    biotechnology dna fda
    Op-Eds

    Fifty years of modern biotech, and an appetite for change

    Andrew Barnhill, Abe Sinay-Smith -
    June 8, 2026 10:00 am
    0
    Disposable flavored electronic cigarette devices are displayed for sale at a store in Pinecrest, Fla., June 26, 2023. (AP Photo/Rebecca Blackwell, File)
    Op-Eds

    Trump FDA’s chance to crack down on Chinese black market harming our children

    Richard Burr -
    June 8, 2026 8:00 am
    0
    A pro-abortion activist holds a box of mifepristone pills as demonstrators from both anti-abortion and pro-abortion groups rally outside the Supreme Court.
    Healthcare

    FDA launches mifepristone study after pressure from Trump’s right flank

    Rena Rowe -
    June 5, 2026 11:55 am
    0
    123...186Page 1 of 186
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • Policies and Standards
    • Terms Of Service
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.